Radiogenic side effects after hypofractionated stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated between 1997 and 2007.

PURPOSE To evaluate side effects of hypofractionated stereotactic photon radiotherapy for patients with choroidal melanoma. PATIENTS AND METHODS Two hundred and twelve patients with choroidal melanoma unsuitable for ruthenium-106 brachytherapy or local resection were treated stereotactically at the Medical University of Vienna between 1997 and 2007 with a Linac with 6-MV photon beams in five fractions with 10, 12, or 14 Gy per fraction. Examinations for radiogenic side effects were performed at baseline and every 3 months in the first 2 years, then every 6 months until 5 years and then once a year thereafter until 10 years after radiotherapy. Adverse side effects were assessed using slit-lamp examination, funduscopy, gonioscopy, tonometry, and, if necessary, fundus photography and fluorescein angiography. Evaluations of incidence of side effects are based on an actuarial analysis. RESULTS One hundred and eighty-nine (89.2%) and 168 (79.2%) of the tumors were within 3 mm of the macula and the optic disc, respectively. The five most common radiotherapy side effects were retinopathy and optic neuropathy (114 cases and 107 cases, respectively), cataract development (87 cases), neovascular glaucoma (46 cases), and corneal epithelium defects (41 cases). In total, 33.6%, 38.5%, 51.2%, 75.5%, and 77.6% of the patients were free of any radiation retinopathy, optic neuropathy, cataract, neovascular glaucoma, or corneal epithelium defects 5 years after radiotherapy, respectively. CONCLUSION In centrally located choroidal melanoma hypofractionated stereotactic photon radiotherapy shows a low to moderate rate of adverse long-term side effects comparable with those after proton beam radiotherapy. Future fractionation schemes should seek to further reduce adverse side effects rate while maintaining excellent local tumor control.

[1]  T. Wiegel,et al.  Proton Therapy of Uveal Melanomas in Berlin , 2004, Strahlentherapie und Onkologie.

[2]  N. Naus,et al.  Cellular radiosensitivity of primary and metastatic human uveal melanoma cell lines. , 2002, Investigative ophthalmology & visual science.

[3]  T. Kiuchi,et al.  Specular microscopic study of X-ray-irradiated rabbit cornea , 2004, Eye.

[4]  R. Pötter,et al.  Impact of a micromultileaf collimator on stereotactic radiotherapy of uveal melanoma. , 2003, International journal of radiation oncology, biology, physics.

[5]  S. Packer,et al.  Iodine-125 radiation of posterior uveal melanoma. , 1987, Ophthalmology.

[6]  R. V. Campo,et al.  Acute and chronic keratitis with ulceration after corneal exposure to helium ion irradiation. , 1987, American journal of ophthalmology.

[7]  Neovascular glaucoma after stereotactic radiotherapy for juxtapapillary choroidal melanoma: histopathologic and dosimetric findings. , 2011, International journal of radiation oncology, biology, physics.

[8]  Ann Schalenbourg,et al.  Eye retention after proton beam radiotherapy for uveal melanoma. , 2003, International journal of radiation oncology, biology, physics.

[9]  R. Liščák,et al.  Leksell gamma knife treatment of uveal melanoma. , 2002, Journal of neurosurgery.

[10]  Ivana K. Kim,et al.  Natural history of radiation papillopathy after proton beam irradiation of parapapillary melanoma. , 2010, Ophthalmology.

[11]  G. Lundell,et al.  Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population. , 2005, Ophthalmology.

[12]  E. Gragoudas,et al.  Uveal melanoma: proton beam irradiation. , 2005, Ophthalmology clinics of North America.

[13]  R. Pötter,et al.  LINAC based stereotactic radiotherapy of uveal melanoma: 4 years clinical experience. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  M Schemper,et al.  A note on quantifying follow-up in studies of failure time. , 1996, Controlled clinical trials.

[15]  E. van Limbergen,et al.  18 Years’ experience with high dose rate strontium-90 brachytherapy of small to medium sized posterior uveal melanoma , 2005, British Journal of Ophthalmology.

[16]  E. Schuster,et al.  Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma , 2000, Graefe's Archive for Clinical and Experimental Ophthalmology.

[17]  C. Shields,et al.  Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients. , 2000, Archives of ophthalmology.

[18]  R Pötter,et al.  A linac-based stereotactic irradiation technique of uveal melanoma. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  B. Damato,et al.  Endoresection of choroidal melanoma , 1998, The British journal of ophthalmology.

[20]  P. Rama,et al.  Gamma knife radiosurgery for uveal melanoma: 12 years of experience , 2008, British Journal of Ophthalmology.

[21]  B. Damato,et al.  Proton beam radiotherapy of choroidal melanoma: the Liverpool-Clatterbridge experience. , 2005, International journal of radiation oncology, biology, physics.

[22]  R. Glynn,et al.  Epidemiologic aspects of uveal melanoma. , 1988, Survey of ophthalmology.

[23]  E. Gragoudas.  Proton beam irradiation of uveal melanomas: the first 30 years. The Weisenfeld Lecture. , 2006, Investigative ophthalmology & visual science.

[24]  T. Oshika,et al.  Long-Term Changes in Rabbit Cornea After Ionizing Radiation , 2004, Cornea.

[25]  Stefan Sacu,et al.  Local tumor control, visual acuity, and survival after hypofractionated stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated between 1997 and 2007. , 2011, International journal of radiation oncology, biology, physics.

[26]  M. Jager,et al.  Angiogenesis and vascular endothelial growth factors in intraocular tumors. , 2010, Developments in ophthalmology.

[27]  E. Gragoudas,et al.  Lens changes after proton beam irradiation for uveal melanoma. , 1995, American journal of ophthalmology.

[28]  H. Withers,et al.  Single-dose compared with fractionated-dose radiation of the OM431 choroidal melanoma cell line. , 1995, American journal of ophthalmology.

[29]  A. Sahgal,et al.  Stereotactic radiotherapy for treatment of juxtapapillary choroidal melanoma: 3-year follow-up , 2009, British Journal of Ophthalmology.

[30]  T L Phillips,et al.  15 years experience with helium ion radiotherapy for uveal melanoma. , 1997, International journal of radiation oncology, biology, physics.

[31]  E. Gragoudas,et al.  A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. , 2000, Archives of ophthalmology.

[32]  Ugur Selek,et al.  Initial results of fractionated CyberKnife radiosurgery for uveal melanoma , 2009, Journal of Neuro-Oncology.

[33]  A. Berghold,et al.  Incidence of radiation retinopathy after high-dosage single-fraction gamma knife radiosurgery for choroidal melanoma. , 2002, Ophthalmology.

[34]  T. Boehringer,et al.  Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. , 2001, International journal of radiation oncology, biology, physics.

[35]  A. Tarkkanen,et al.  Iodine brachytherapy as an alternative to enucleation for large uveal melanomas. , 2003, Ophthalmology.

[36]  H. Guss,et al.  Gamma knife radiosurgery for uveal melanomas: an 8-year experience. , 2000, Journal of neurosurgery.

[37]  Melania Pintilie,et al.  Analysing and interpreting competing risk data , 2007, Statistics in medicine.

[38]  J. Fraumeni,et al.  Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. , 1976, Journal of the National Cancer Institute.

[39]  P Gastaud,et al.  Results of proton therapy of uveal melanomas treated in Nice. , 1999, International journal of radiation oncology, biology, physics.

[40]  L. Desjardins,et al.  Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO). , 2006, International journal of radiation oncology, biology, physics.

[41]  B. Damato.  Developments in the management of uveal melanoma , 2004, Clinical & experimental ophthalmology.

[42]  B. Damato.  Treatment of primary intraocular melanoma , 2006, Expert review of anticancer therapy.

[43]  A. Tarkkanen,et al.  Histopathology of enucleated intraocular melanomas irradiated with cobalt and ruthenium plaques , 1988, Acta ophthalmologica.

[44]  D. Char,et al.  Uveal tumour resection , 2001, The British journal of ophthalmology.

[45]  H. Withers,et al.  Effects of gamma radiation on the OM431 human ocular melanoma cell line. , 1995, Experimental eye research.

[46]  P. Levendag,et al.  Effectiveness of fractionated stereotactic radiotherapy for uveal melanoma. , 2004, International journal of radiation oncology, biology, physics.

[47]  J. Gérard,et al.  Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays). , 2004, American journal of ophthalmology.